Trial Profile
PV-10 Intralesional Injection vs Systemic Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 13 Mar 2024
Price :
$35
*
At a glance
- Drugs Rose bengal sodium (Primary) ; Dacarbazine; Talimogene laherparepvec; Temozolomide
- Indications Malignant melanoma
- Focus Registrational; Therapeutic Use
- Sponsors Provectus Biopharmaceuticals
- 19 Jan 2022 Status changed to discontinued.
- 27 Sep 2021 According to Provectus Biopharmaceuticals media release, data from this study will be presented on two poster presentations at the SMR 2021 Congress (the Society for Melanoma Research annual meeting).
- 30 Sep 2019 Status changed from active, no longer recruiting to discontinued.